1) Dech B, Budow L:The use of fluoxetine in an adolescent with Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 30:298-302, 1991
2) Dimitropoulos A, Schultz RT:Food-related neural circuitry in Prader-Willi syndrome:Response to high-versus low-calorie foods. J Autism Dev Disord 38:1642-1653, 2008
3) Dykens EM, Hodapp RM, Walsh K, et al:Adaptive and maladaptive behavior in Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 31:1131-1136, 1992
4) Dykens EM, Cassidy SB:Handbook of neurobehavioral and genetic disorders in children. In:Goldstein S, Reynolds CR, ed. Prader-Willi syndrome. Guilford Press, New York, pp525-554, 1999
5) Dykens EM, Shah B:Psychiatric disorders in Prader-Willi syndrome:Epidemiology and management. CNS Drugs 17:167-178, 2003
6) Dykens EM, Maxwell MA, Pantino E, et al:Assessment of hyperphagia in Prader-Willi syndrome. Obesity(Silver Spring)15:1816-1826, 2007
7) Einfeld SL, Smith E, McGregor IS, et al:A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome. Am J Med Genet A 164A:2232-2239, 2014
8) Fieldstone A, Zipf WB, Schwartz HC, et al:Food preferences in Prader-Willi syndrome, normal weight and obese controls. Int J Obes Relat Metab Disord 21:1046-1052, 1997
9) Forster JL, Gourash LM:Managing Prader-Willi Syndrome:A Primer for Psychiatrists. In:Pittsburgh Partnership. Pittsburgh, pp1-8, 2005
10) Gito M, Ihara H, Ogata H, et al:Gender Differences in the Behavioral Symptom Severity of Prader-Willi Syndrome. Behav Neurol 2015:294127, 2015
11) Goldstone AP, Holland AJ, Hauffa BP, et al:Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab 93:4183-4197, 2008
12) 長谷川真理,位田忍,惠谷ゆり,他:当センターにおけるPrader-Willi症候群の包括的フォローアップ—「母子センターPWSの会」の取り組み.大阪府立母子保健総合医療センター雑誌 29:15-20, 2013
13) Hellings JA, Warnock JK:Self-injurious behavior and serotonin in Prader-Willi syndrome. Psychopharmacol Bull 30:245-250, 1994
14) Hinton EC, Holland AJ, Gellatly MS, et al:Neural representations of hunger and satiety in Prader-Willi syndrome. Int J Obes(Lond)30:313-321, 2006
15) Ho AY, Dimitropoulos A:Clinical management of behavioral characteristics of Prader-Willi syndrome. Neuropsychiatr Dis Treat 6:107-118, 2010
16) Hoffman CJ, Aultman D, Pipes P:A nutrition survey of and recommendations for individuals with Prader-Willi syndrome who live in group homes. J Am Diet Assoc 92:823-830, 833, 1992
17) Holland AJ, Treasure J, Coskeran P, et al:Measurement of excessive appetite and metabolic changes in Prader-Willi syndrome. Int J Obes Relat Metab Disord 17:527-532, 1993
18) Holland AJ, Treasure J, Coskeran P, et al:Characteristics of the eating disorder in Prader-Willi syndrome:Implications for treatment. J Intellect Disabil Res 39(Pt 5):373-381, 1995
19) Holsen LM, Zarcone JR, Brooks WM, et al:Neural mechanisms underlying hyperphagia in Prader-Willi syndrome. Obesity(Silver Spring)14:1028-1037, 2006
20) Ihara H, Ogata H, Sayama M, et al:QOL in caregivers of Japanese patients with Prader-Willi syndrome with reference to age and genotype. Am J Med Genet A 164A:2226-2231, 2014
21) Itoh M, Koeda T, Ohno K, et al:Effects of mazindol in two patients with Prader-Willi syndrome. Pediatr Neurol 13:349-351, 1995
22) Kohn Y, Weizman A, Apter A:Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine. Int J Eat Disord 30:113-117, 2001
23) Lindgren AC, Barkeling B, Hagg A, et al:Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups. J Pediatr 137:50-55, 2000
24) McAllister CJ, Whittington JE, Holland AJ:Development of the eating behaviour in Prader-Willi Syndrome:Advances in our understanding. Int J Obes(Lond)35:188-197, 2011
25) McAllister CJ, Whittington JE:A short clinical overview of Prader-Willi syndrome. Clin Obes 1:184-188, 2011
26) Miller JL, Lynn CH, Driscoll DC, et al:Nutritional phases in Prader-Willi syndrome. Am J Med Genet A 155A:1040-1049, 2011
27) Nagai T, Mori M:Prader-Willi syndrome, diabetes mellitus and hypogonadism. Biomed Pharmacother 53:452-454, 1999
28) Ogata H, Ihara H, Murakami N, et al:Autism spectrum disorders and hyperactive/impulsive behaviors in Japanese patients with Prader-Willi syndrome:A comparison between maternal uniparental disomy and deletion cases. Am J Med Genet A 164A:2180-2186, 2014
29) Russell H, Oliver C:The assessment of food-related problems in individuals with Prader-Willi syndrome. Br J Clin Psychol 42:379-392, 2003
30) Smathers SA, Wilson JG, Nigro MA:Topiramate effectiveness in Prader-Willi syndrome. Pediatr Neurol 28:130-133, 2003
31) Song DK, Sawada M, Yokota S, et al:Comparative analysis of autistic traits and behavioral disorders in Prader-Willi syndrome and Asperger disorder. Am J Med Genet A 167A:64-68, 2015
32) Swaab DF, Purba JS, Hofman MA:Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons(putative satiety cells)in Prader-Willi syndrome:A study of five cases. J Clin Endocrinol Metab 80:573-579, 1995
33) 高木亜希子,法橋尚宏:Prader-Willi症候群児の食事療法とその母親のQOLとの関係.日本小児看護学会誌 15:15-21, 2006
34) Tauber M, Mantoulan C, Copet P, et al:Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome:A randomised placebo-controlled trial in 24 patients. Orphanet J Rare Dis 6:47, 2011
35) Taylor RL, Caldwell ML:Type and strength of food preferences of individuals with Prader-Willi syndrome. J Ment Defic Res 29(Pt 1):109-112, 1985
36) Whittington JE, Holland AJ, Webb T, et al:Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 38:792-798, 2001